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Abstract	(246	words)	17	
Background:	 Regular	 intense	 endurance	 exercise	 can	 lead	 to	 amenorrhea	 with	 possible	18	
adverse	consequences	for	bone	health.		19	
Objective:	 We	 compared	 whole-body	 and	 regional	 bone	 strength	 and	 skeletal	 muscle	20	
characteristics	 between	 amenorrheic	 (AA:	 n=14)	 and	 eumenorrheic	 (EA:	 n=15)	 elite	 adult	21	
female	long	distance	runners	and	non-athletic	controls	(C:	n=15).		22	
Study	design	and	Participants:	Participants	completed	three-day	food	diaries,	dual	energy	x-23	
ray	 absorptiometry	 (DXA),	 magnetic	 resonance	 imaging	 (MRI),	 peripheral	 quantitative	24	
computed	tomography	(pQCT)	and	isometric	maximal	voluntary	knee	extension	contraction	25	
(MVC).	26	





and	 EA	 than	C,	whereas	 in	 the	 radius	 only	 the	 proximal	 Iy	was	 larger	 in	 EA	 than	C.	 Knee	32	
extensor	MVC	did	not	differ	significantly	between	groups.		33	
Conclusions:	 Amenorrheic	 adult	 female	elite	 long-distance	 runners	had	 lower	BMD	 in	 the	34	
trunk,	lumbar	spine,	ribs	and	pelvis	than	eumenorrheic	athletes	and	controls.	The	radius	and	35	
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Introduction	40	





The	mechanostat	 theory	 states	 that	bone	adapts	 to	 increased	mechanical	 loading	 (impact	46	














in	 1997	 as	 a	 simultaneous	 occurrence	 of	 amenorrhea,	 inadequate	 food	 intake	 and	 high	61	
training	 volume	 [18]	 that	 all	 have	 a	 negative	 impact	 on	 bone	 health.	 Most	 studies	 that	62	
considered	the	effects	of	amenorrhea	on	bone	used	dual-energy	x-ray	absorptiometry	(DXA)	63	
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(e.g.	 [16,	 17]).	 	 Using	 DXA,	 higher	 BMD	 and	 strength	 indicators	were	 found	 at	 the	 hip	 in	64	
eumenorrheic	 athletes	 than	 controls,	 while	 no	 such	 differences	 were	 seen	 between	65	





suggest	 that	 there	 is	 a	deficit	 in	bone	health	 in	 amenorrheic	 adolescent	 athletes	 and	 it	 is	71	






adult	 amenorrheic	 elite	 athletes	have	 low	muscle	mass	 and/or	quality	of	 specific	muscles	78	





The	 aim	 of	 the	 present	 study	 was	 to	 examine	 the	 interrelationship	 of	 muscle	 and	 bone	84	
characteristics	 in	female,	adult	elite-level	endurance	athletes	affected	by	amenorrhea.	The	85	
primary	hypothesis	was	 that	amenorrheic	athletes	have	 lower	 indicators	of	bone	strength	86	
than	eumenorrheic	athletes	and	controls	 in	body	 segments	with	 lower	direct	exposure	 to	87	












cycle	 history.	 All	 non-athletic	 controls	 were	 recruited	 from	 the	 local	 student	 population,	98	
performed	less	than	2	hours	of	physical	activity	per	week	and	did	not	take	part	 in	athletic	99	
competitions.	 Participants	were	 asked	 about	 the	 phase	 of	menstrual	 cycle	 at	 the	 date	 of	100	
testing,	use	of	oral	contraceptive	pills	(OCP),	any	current	medication,	smoking	habits,	age	of	101	






volunteers	were	excluded	 if	 they	were	pregnant	or	 potentially	 pregnant.	 The	Manchester	108	
Metropolitan	 University	 Ethics	 Committee	 approved	 the	 study	 and	 all	 participants	 gave	109	
written	informed	consent.	Table	1	shows	the	participant	characteristics.		110	
	111	

















10.50.086).	 This	 calculated	 the	 cross-sectional	 area	 (CSA),	 the	 cross-sectional	 moment	 of	127	
inertia	(CSMI:	an	index	of	structural	rigidity),	the	width	of	the	neck	and	shaft	of	the	femur	and	128	
the	bone	strength	index,	a	ratio	of	estimated	compressive	yield	strength	of	the	femoral	neck	129	










functions	 derived	 from	 scans	 of	 different	 density	 regions	 within	 the	 same	manufacturer-138	
provided	phantom	on	each	scanner.	The	dominant	arm	was	identified	as	the	writing	arm,	and	139	
in	 any	 cases	 of	 ambidexterity,	 the	 dominant	 arm	was	 defined	 as	 the	 favoured	 arm	when	140	
playing	racquet	sports.	The	non-dominant	leg	was	defined	as	the	leg	that	was	preferentially	141	
used	for	hopping.	Scans	were	taken	at	4	and	60%	of	the	radius	length,	and	4	and	66%	of	the	142	









total	 bone	 mineral	 content	 (vBMC.tot,	 mg·mm-1)	 and	 trabecular	 bone	 mineral	 density	152	




corrected	 for	 the	 partial	 volume	 effect	 as	 described	 previously	 [22].	 The	 coefficient	 of	157	

















around	 900	 and	 straps	 fastened	 around	 the	 hip.	 Participants	 performed	 three	 maximum	173	




Statistical	 analysis	was	performed	on	data	normalised	 to	object	 length	or	body	height,	 to	178	
remove	any	variability	caused	by	differences	in	these	factors,	with	SPSSv19	(IBM,	USA).	Data	179	
was	normally	distributed	as	assessed	using	the	Kolmogrov-Smirnov	test.		A	one-way	ANOVA	180	
was	 used	 to	 assess	 any	 significant	 differences	 between	 control,	 amenorrheic	 and	181	
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Table	2	 shows	 that	 there	was	no	 significant	difference	 in	 forearm	and	 tibia	muscle	 cross-210	
sectional	 area,	 and	 calf	 and	quadriceps	muscle	 volume	between	any	groups.	Both	athlete	211	
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For	 the	 diaphysis	 of	 both	 the	 radius	 and	 the	 tibia	 the	 cortical	 thickness	 did	 not	 differ	252	





















This	 confirmed	 that	 the	 recruited	 athletes	 were	 indeed	 elite	 athletes.	 The	 athletes	 were	274	
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classified	 as	 amenorrheic	 if	 they	 self-reported	 an	 absence	 of	 menses	 for	 at	 least	 12	275	


















According	 to	 the	 mechanostat	 theory	 [4],	 mechanical	 strain	 on	 bone,	 caused	 by	 muscle	294	
contraction,	 stimulates	 bone	 formation	 and	 increases	 bone	 strength	 [3,	 4].	 Effects	 of	295	
amenorrhea	may	thus	be	secondary	to	muscle	weakness	or	a	loss	of	muscle	mass.	We	do	not	296	
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think	 low	muscle	mass	or	weakness	was	a	major	consideration	in	our	study	because	there	297	














controls	 [6].	 However	 in	 the	 current	 study	 it	 was	 observed	 that	 in	 contrast	 to	 the	 trunk	312	
skeleton,	in	the	radius	the	bone	mineral	density	was	similar,	and	not	less,	in	amenorrheic	than	313	
eumenorrheic	 athletes	 and	 controls.	 Such	a	difference	between	bones	 in	 the	 response	 to	314	
amenorrhea	has	been	observed	previously;	where	bone	mineral	 density	was	 lower	 in	 the	315	
lumbar	vertebrae,	but	not	in	the	radius	and	the	femur	[28].	It	has	been	suggested	that	the	316	
loss	of	bone	mineral	density	in	the	lumbar	vertebrae	is	due	to	loss	of	body	mass	rather	than	317	
amenorrhea	 per	 se	 [29].	 This	 indeed	 corresponds	 with	 the	 lower	 body	 mass	 of	 the	318	
amenorrheic	 athletes,	 but	 is	 at	 odds	 with	 the	 similar	 bone	 mineral	 density	 in	 the	 trunk	319	
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adaptations	 to	 exercise	may	 be	 site-specific	 [35].	 Nevertheless,	 we	 found	 that	 bone	 size,	342	
strength	and	cortical	bone	area	of	the	diaphysis	was	larger	in	athletes	than	controls,	with	no	343	
significant	differences	between	amenorrheic	and	eumenorrheic	athletes,	except	for	the	larger	344	
epiphyseal	 bone	 strength	 (indicated	 by	 total	 bone	 mass)	 over	 controls	 in	 eumenorrheic	345	










during	 pregnancy.	 This	 pregnancy-induced	 loss	 of	 BMD	 can	 be	 recovered	 during	 lactation	356	
when	the	child	is	weaned	[39,	40]	and	if	the	underlying	cause	is	similar,	the	expansion	of	the	357	
endocortical	 circumference	 in	 the	amenorrheic	 athletes	 could	most	 likely	be	 recovered	by	358	
normalisation	of	the	menstrual	cycle.	In	a	study	of	monozygotic	twins,	hormone	replacement	359	
therapy	(HRT)	was	associated	with	larger	cortical	bone	areas	and	smaller	endocortical	areas	360	
[38].	 It	 is	 not	 known,	 however,	 if	 this	 would	 be	 effective	 in	 amenorrheic	 athletes	 as	 the	361	
duration	of	HRT	 in	 the	 twins	 study	was	on	average	8	years.	Although	 regular	exercise	was	362	
associated	 with	 a	 smaller	 endocortical	 area	 in	 monozygotic	 twins	 [35]	 it	 is	 unlikely	 that	363	
normalisation	of	the	endocortical	circumference	in	amenorrheic	athletes	can	be	realised	by	364	






It	was	 not	 possible	 to	 include	 energy-deficient	 amenorrheic	 athletes	 in	 the	 current	 study,	369	
which	may	have	offered	further	insights.	However,	this	might	equally	be	seen	as	a	strength	of	370	
our	 study	 because	we	were	 able	 to	 rule	 out	 the	 contribution	 of	 energy	 deficiency	 to	 our	371	
observations.	 Circulating	 levels	 of	 oestrogen	 were	 not	 measured	 which	 may	 have	372	
complemented	the	assessment	of	amenorrhea.	However,	oestrogen	levels	vary	considerably	373	
during	 the	 menstrual	 cycle	 and	 diurnally,	 complicating	 distinction	 of	 eumonorrheic	 and	374	
amenorrheic	athletes.	Five	of	the	athletes	stated	they	were	taking	the	oral	contraceptive	pill	375	
(OCP)	for	contraceptive	reasons	only.	One	AA	who	took	OCP	still	suffered	from	amenorrhea	376	






athletes	 is	 not	 entirely	 explained	 by	 reduced	 loading,	 but	 rather	 suggests	 that	 the	 bone	383	
response	to	amenorrhea	is	site-specific.	While	the	strength	of	weight	bearing	bones	in	the	EA	384	
and	AA	are	similar,	the	enlargement	of	the	endocortical	area,	similar	to	that	shown	by	Mikkola	385	




















































































































































Age	(Years)	 26.8±0.9	 27.6±2.1	 26.4±0.8	 0.863	 0.714	 0.594	
Height	(m)	 1.66±0.17	 1.66±0.02	 1.64±0.02	 0.590	 0.862	 0.479	
Mass	(kg)	 59.6±1.5	 54.5±1.3	 49.6±1.6	 <0.0005	 0.037	 0.029	
BMI	(kg·m-2)	 21.7±0.6	 19.8±0.4	 18.3±0.4	 <0.0005	 0.009	 0.045	
Lean	mass	(kg)	 39.0±1.6	 44.5±1.1	 42.0±1.2	 0.112	 0.015	 0.215	
Fat	mass	(kg)	 18.5±1.5	 8.1±0.7	 5.3±0.6	 <0.0005	 <0.0005	 0.054	
Body	fat	mass	(%)	 30.6±2.1	 14.9±1.2	 10.7±1.0	 <0.0005	 <0.0005	 0.065	
Lean	mass	(%)	 65.4±2.2	 82.4±1.2	 86.8±1.1	 <0.0005	 <0.0005	 0.059	
AGP	(%)	 N/A	 86.9±1.0	 86.6±1.2	 N/A	 N/A	 0.890	
Age	of	menarche		
(years)	



















	 C	 EA	 AA	 P	VALUE	











6457±221	 7002±193	 7099±242	 0.225	 0.944	 0.198	
Calf	Volume	(cm³)	 1316±70	 1317±74	 1325±86	 0.670	 0.556	 0.884	
Quadriceps	Volume	(cm³)	 1239±89	 1469±92	 1461±80	 0.146	 0.157	 0.951	
Quadriceps	Strength	(Nm)	 171±6	 164±7	 163±10	 0.314	 0.304	 0.992	
Normalised	Force	(Nm.cm¯³)	 0.141±0.008	 0.115±0.007	 0.117±0.007	 0.045	 0.035	 0.921	




	 C	 EA	 AA	 P	VALUE	(AD	FOR	BODY	HEIGHT)	
	 n=15	 n	=15	 n=14	 C	vs.	AA	 C	vs.	EA	 AA	vs.	EA	
Total	(g·cm-2)	 1.17±0.02	 1.19±0.01	 1.13±0.03	 0.318	 0.365	 0.064	
Arms	(g·cm-2)	 0.82±0.01	 0.83±0.01	 0.81±0.03	 0.715	 0.575	 0.364	
Average	Hip	(g·cm-2)	 1.06±0.04	 1.12±0.03	 1.02±0.04	 0.435	 0.302	 0.078	
Trunk	(g·cm-2)	 0.91±0.03	 0.91±0.02	 0.82±0.02	 0.002	 0.909	 0.003	
Ribs	(g·cm-2)	 0.68±0.02	 0.65±0.02	 0.62±0.01	 0.005	 0.100	 0.198	
Spine	L1-4	(g·cm-2)	 1.19±0.03	 1.16±0.03	 1.04±0.04	 0.004	 0.585	 0.015	
Pelvis	(g·cm-2)	 1.11±0.01	 1.14±0.02	 0.99±0.03	 0.004	 0.568	 0.001	





















Cortical	width	shaft	(mm)	 3.73±0.33	 5.68±0.41	 4.89±0.43	 0.034	 0.001	 0.182	
Cortical	width	neck	(mm)	 6.16±0.59	 7.20±0.50	 6.89±0.40	 0.411	 0.198	 0.642	
CSA	femoral	neck	(mm2)	 146±7.9	 158±4.7	 146±5.7	 0.698	 0.255	 0.134	
Strength	Index	(BSI)	 1.69±0.10	 1.81±0.07	 1.89±0.11	 0.161	 0.398	 0.570	
CSMI	(mm4)	 9645±601	 9840±676	 8645±524	 0.056	 0.847	 0.086	
Femur	CSA	(cm²)	 10.5±1.1	 16.4±0.9		 15.9±2.0		 0.013	 0.005	 0.788	
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Table	5.	Peripheral	quantitative	computer	tomography	(pQCT)	data	for	the	Radius	epiphysis	536	






vBMDtb	 (mgmm-³):	 Trabecular	 bone	mineral	 density;	 Artot	 (mm²);	 Arct	 (mm²):	 Cortical	543	
Area:	EcC	(mm):	Endochondral	circumference;	Iy	and	Ix,	(mm4):	moment	of	inertia	indicating	544	





	 C	 EA	 AA	 P	VALUE	(AD	FOR	RADIUS	LENGTH)	
	 n=15	 n=15	 n=14	 C	vs.	AA	 C	vs.	EA	 AA	vs.	EA	
RE	Ar.tot	(mm2)	 319±14	 367±14	 365±15	 0.035	 0.023	 0.931	
RE	vBMC.tot	(mg.mm-¹)	 101±4	 109±4	 102±6	 0.861	 0.220	 0.304	
RE	vBMD.tb	(mg.mm-³)	 186±9	 197±11	 197±15	 0.604	 0.576	 0.984	
RD	Ar.tot	(mm2)	 102±4	 111±3	 112±4	 0.034	 0.045	 0.839	
RD	vBMC.tot	(mg.mm-1)	 93.0±4.0	 103.2±4.0	 98.9±4.3	 0.997	 0.336	 0.529	
RD	vBMDct	(mg.mm-3)	 1132±14	 1144±8	 1142±11	 0.819	 0.721	 0.907	
RD	Iy	(mm
4
)	 138±7	 158±7	 156±7	 0.067	 0.032	 0.801	
RD	Ix	(mm
4
)	 135±8	 149±8	 151±8	 0.165	 0.190	 0.896	






	 C	 EA	 AA	 P	VALUE	(AD	FOR	TIBIA	LENTGH)	
	 n=15	 n=15	 n=14	 C	vs.	AA	 C	vs.	EA	 AA	vs.	EA	
TE	vBMC.tot	(mg·mm-¹)	 296±11	 337±11	 324±12	 0.147	 0.012	 0.858	
TE	vBMD.tb	(mg·mm-³)	 232±12	 263±10	 265±10	 0.024	 0.028	 0.091	
TE	Ar.tot	(mm²)	 977±36	 1067±32	 1056±34	 0.032	 0.032	 0.437	
TD	Ar.tot	(mm2)	 436±17	 500±11	 522±22	 <0.0005	 0.004	 0.213	
TD	vBMC.tot	(mg·mm-¹)	 312±9	 390±8	 364±10	 0.006	 <0.0005	 0.153	
TD	vBMD.ct	(mg·mm-3)	 1127±7	 1122±7	 1112±8	 0.02	 <0.0005	 0.280	
TD	Ix	(mm
4
)	 1288±58	 1580±60	 1696±63	 <0.0005	 0.001	 0.237	
TD	Iy	(mm
4
)	 863±41	 1077±43	 1071±45	 0.004	 <0.0005	 0.599	
	554	
TE:	 Tibia	epiphysis;	 TD:	Tibia	diaphysis;	 vBMDct	 (mg·mm-³):	Cortical	bone	mineral	density;	555	
vBMDtb	 (mgmm-³):	 Trabecular	 bone	mineral	 density;	 Artot	 (mm²);	 Arct	 (mm²):	 Cortical	556	
Area:	EcC	(mm):	Endochondral	circumference;	Iy	and	Ix,	(mm4):	moment	of	inertia	indicating	557	
bone’s	 stiffness	 in	 bending	 perpendicular	 to	 line	 of	 flexion/extension,	 in	 line	 with	558	
flexion/extension	and	torsion	respectively.	Data	are	presented	as	mean	±	SEM.	559	
	 	560	
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